Queen Mary University of London: Drug Slows Progression of MS
May 28, 2026
May 28, 2026
LONDON, England, May 28 (TNSjou) -- Queen Mary University of London issued the following news:
* * *
Drug slows progression of MS
Trial results show that ocrelizumab helps preserve hand function and reduce the risk of wheelchair dependence in people with primary progressive multiple sclerosis (MS).
-
A major international phase III clinical trial, led by Queen Mary University of London, has found that ocrelizumab - a medication alr . . .
* * *
Drug slows progression of MS
Trial results show that ocrelizumab helps preserve hand function and reduce the risk of wheelchair dependence in people with primary progressive multiple sclerosis (MS).
-
A major international phase III clinical trial, led by Queen Mary University of London, has found that ocrelizumab - a medication alr . . .